| Name | Title | Contact Details |
|---|
Certol International is a Commerce City, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SurgiMa is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Lexington, MA, iSpecimen offers an online marketplace for the purchase of human biospecimens, providing researchers with the specimens they need from the patients they want. The iSpecimen Marketplace connects healthcare organizations that have access to patients and specimens with the scientists who need them for their research and development projects. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all.
Smiths Medical is a leading global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the hospital, emergency, home and specialist environments. Our products are used during critical and intensive care, surgery, post-operative care during recovery, and in a series of home infusion therapies. We offer a number of some of the most respected and easily recognizable brands in the specialty device space: Portex™, Medex™, Deltec™, Level1™, Pneupac™, Wallace™, CADD™, BCI™, Jelco™, Medfusion™ and Surgivet™. Smiths Medical employs some 7,500 people, with manufacturing concentrated in the US, the UK, Mexico and Italy. Most territories are serviced through wholly-owned local sales and distribution companies. Smiths Medical is part of Smiths Group, a world leader in the practical application of technologies, delivering products and services for the threat & contraband detection, medical device, energy and communications markets worldwide. Smiths Group employs over 23,000 people in more than 50 countries.
NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.